20 results match your criteria: "University Hospital of Setif[Affiliation]"
Article Synopsis
- * Recent efforts to stop smoking haven't been put into action yet, and it’s important to see what could happen if smoking rates stay the same or improve.
- * Researchers used models to predict health outcomes by 2050 based on different scenarios of smoking rates, showing that cutting smoking could greatly improve health and life expectancy.
Antioxidant and anti-inflammatory potentials of Ammodaucus leucotrichus Coss. & Durieu seeds' extracts: In vitro and in vivo studies.
J Ethnopharmacol
May 2024
Laboratory of Applied Biochemistry, Faculty of Nature and Life Sciences, Setif 1 University, Setif, 19000, Algeria. Electronic address:
Ethnopharmacological Relevance: Ammodaucus leucotrichus Coss. & Durieu (Apiaceae) is traditionally used in southern Algeria as a remedy against a wide range of disease due to its health-promoting properties.
Aim Of The Study: To investigate anti-oxidant and anti-inflammatory potentials of plant methanolic extract and its fractions in vitro and in vivo.
Cardiomyopathy, carnitine deficiency, and celiac disease.
Eur J Pediatr
May 2024
LMCVGN Research Laboratory, Faculty of Medicine, University of Setif, Campus El Bez, 19000, Setif, Algeria.
Probiotics for atopic dermatitis.
Clin Med (Lond)
July 2021
Setif-1 University, Setif, Algeria and University Hospital of Setif, Setif, Algeria.
Letter to the Editor: Morphea, Gluten, and Autoimmunity: HLA Behind the Scenes?
Kans J Med
September 2021
Faculty of Medicine, LMCVGN Research Laboratory, Ferhat Abbas Setif-1 University, Algeria.
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
Inj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Background: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria.
Methods: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation.
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017.
Inj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Article Synopsis
- Injuries significantly impact global health, with the number of injury deaths rising from approximately 4.26 million in 1990 to about 4.48 million in 2017, despite a decline in age-standardized mortality rates.
- The Global Burden of Disease study measured both fatal and non-fatal injuries through years of life lost (YLLs) and years lived with disability (YLDs), which were combined into disability-adjusted life years (DALYs).
- While overall injury incidence increased, age-standardized DALYs decreased, indicating a need for ongoing research focused on injury prevention, better data collection, and improving access to medical care in high-burden areas.
Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017.
Inj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Article Synopsis
- - The study investigates how sociodemographic factors relate to injury-related health outcomes worldwide, specifically analyzing disability-adjusted life years (DALYs) from injuries across 195 countries from 1990 to 2017.
- - Findings show that while most injury causes display a trend of decreasing DALY rates with higher Socio-demographic Index (SDI), certain injuries like road injuries, interpersonal violence, and self-harm deviate from this trend, indicating complex underlying factors.
- - The research highlights the importance of understanding these injury patterns to improve health strategies and intervention efforts at both national and global levels, especially since not all injuries follow the same developmental trajectory.
Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study.
Inj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Article Synopsis
- Past research highlights that fires and hot substances are significant global health risks, causing morbidity and mortality that necessitate better preventative strategies and healthcare access.
- Using the Global Burden of Disease 2017 framework, the study calculated various health metrics related to fire-related injuries across 195 countries from 1990 to 2017.
- Findings indicate that while global mortality rates from these injuries have declined, there is considerable regional variation, with middle and lower-income areas being more affected and requiring improved safety resources and healthcare infrastructure.*
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.
JAMA Oncol
December 2019
Institute for Health Metrics and Evaluation, University of Washington, Seattle.
Article Synopsis
- Cancer and other noncommunicable diseases (NCDs) pose a significant threat to global development, with slow progress in addressing these issues highlighted by the recent UN meeting; key barriers include a lack of situational analyses and prioritization for effective action against NCDs.* -
- The study aims to provide comprehensive data on cancer burden across 29 cancer types in 195 countries from 1990 to 2017, utilizing the Global Burden of Disease (GBD) methods to analyze cancer incidence, mortality, and disability metrics.* -
- In 2017, there were 24.5 million new cancer cases globally, with significant variations based on socio-demographic factors; the majority of cancer-related disabilities stemmed
Global Mortality From Firearms, 1990-2016.
JAMA
August 2018
Institute for Health Metrics and Evaluation, University of Washington, Seattle.
Importance: Understanding global variation in firearm mortality rates could guide prevention policies and interventions.
Objective: To estimate mortality due to firearm injury deaths from 1990 to 2016 in 195 countries and territories.
Design, Setting, And Participants: This study used deidentified aggregated data including 13 812 location-years of vital registration data to generate estimates of levels and rates of death by age-sex-year-location.
The Burden of Cardiovascular Diseases Among US States, 1990-2016.
JAMA Cardiol
May 2018
Institute for Health Metrics and Evaluation, University of Washington, Seattle.
Importance: Cardiovascular disease (CVD) is the leading cause of death in the United States, but regional variation within the United States is large. Comparable and consistent state-level measures of total CVD burden and risk factors have not been produced previously.
Objective: To quantify and describe levels and trends of lost health due to CVD within the United States from 1990 to 2016 as well as risk factors driving these changes.
Nonalcoholic Steatohepatitis.
N Engl J Med
February 2018
University Hospital of Setif, Setif, Algeria
Study of congenital heart diseases in patients with Down syndrome in Algeria.
East Mediterr Health J
November 2017
Private Cardiology Clinic, Sétif, Algeria.
This study aimed to describe and evaluate the type, frequency and patterns of congenital heart diseases (CHDs) in patients with Down Syndrome (DS) in Sétif, Algeria. Down Syndrome, or trisomy 21, is the most common genetic disorder in the world. Data were collected and followed from January 2009 to December 2013.
View Article and Find Full Text PDFHLA genes as a predictive screening tool for celiac disease.
Turk Pediatri Ars
September 2017
Department of Pediatrics, University Hospital of Sétif, Sétif 1 University, Sétif, Cezayir.
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
JAMA Oncol
December 2017
University of Washington, Institute for Health Metrics and Evaluation, Seattle
Importance: Liver cancer is among the leading causes of cancer deaths globally. The most common causes for liver cancer include hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and alcohol use.
Objective: To report results of the Global Burden of Disease (GBD) 2015 study on primary liver cancer incidence, mortality, and disability-adjusted life-years (DALYs) for 195 countries or territories from 1990 to 2015, and present global, regional, and national estimates on the burden of liver cancer attributable to HBV, HCV, alcohol, and an “other” group that encompasses residual causes.
Successful management of MPS hydrocephalus by acetazolamide.
Childs Nerv Syst
December 2017
Pediatrics Department, Setif University Hospital, Setif-1 University, 19000, Setif, Algeria.
Human leukocyte antigen is better than serological screening for celiac diseases in rheumatological arthritis.
Turk J Gastroenterol
May 2017
University Hospital of Setif, Setif 1 University, Pediatrics Setif, Setif, DZ, Algeria.
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
JAMA Oncol
April 2017
Institute for Health Metrics and Evaluation, University of Washington, Seattle.
Importance: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning.
Objective: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015.
Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors: experience from developing countries.
Blood Coagul Fibrinolysis
March 2017
aService d'Hématologie, Hopital Isaad Hassani, CHU Beni-Messous, Alger, Algeria bCollege of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia cSheikh Khalifa Medical City, Abu Dhabi, UAE dNovo Nordisk Healthcare AG, Zurich Oerlikon, Switzerland eDepartment of Child Health, Sultan Qaboos University Hospital, Muscat, Oman fService of Medicine, Cheikh Zaid Hospital, Rabat, Morocco gDepartment of Haematology, Public Hospital of Mascara, Mascara hDepartment of Haematology, University Hospital of Annaba, Annaba iDepartment of Hematology, University Hospital of Sétif, Sétif jDepartment of Haematology, University Hospital Tlemcen, Tlemcen, Algeria kKing Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia lNovo Nordisk Canada Inc., Mississauga, ON, Canada mHaematology Department, University Hospital of Constantine, Constantine nUniversity Hospital Oran, Bd. Dr Benzerjeb, Oran, Algeria.
Home therapy for uncomplicated mild/moderate bleeding can decrease healthcare burden, promote self-esteem, reduce complications, and provide near-normal quality of life. To evaluate recombinant activated factor VII (rFVIIa) as home therapy for joint bleeds in Algeria, Morocco, Oman, Saudi Arabia, and United Arab Emirates. Twenty-seven patients aged more than 2 years with congenital haemophilia and inhibitors were monitored for up to 8 months after a first haemarthrosis episode treated with rFVIIa.
View Article and Find Full Text PDF